CK Life Sciences Int'l. (Holdings) Balance Sheet Health
Financial Health criteria checks 0/6
CK Life Sciences Int'l. (Holdings) has a total shareholder equity of HK$4.2B and total debt of HK$5.4B, which brings its debt-to-equity ratio to 130.1%. Its total assets and total liabilities are HK$11.0B and HK$6.9B respectively. CK Life Sciences Int'l. (Holdings)'s EBIT is HK$232.0M making its interest coverage ratio 1. It has cash and short-term investments of HK$505.9M.
Key information
130.1%
Debt to equity ratio
HK$5.42b
Debt
Interest coverage ratio | 1x |
Cash | HK$505.94m |
Equity | HK$4.17b |
Total liabilities | HK$6.88b |
Total assets | HK$11.05b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 775's short term assets (HK$2.9B) do not cover its short term liabilities (HK$2.9B).
Long Term Liabilities: 775's short term assets (HK$2.9B) do not cover its long term liabilities (HK$4.0B).
Debt to Equity History and Analysis
Debt Level: 775's net debt to equity ratio (117.9%) is considered high.
Reducing Debt: 775's debt to equity ratio has increased from 105.3% to 130.1% over the past 5 years.
Debt Coverage: 775's debt is not well covered by operating cash flow (4.2%).
Interest Coverage: 775's interest payments on its debt are not well covered by EBIT (1x coverage).